FORTIS.NS Profit & Loss
Fortis Healthcare Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 8 years on file
(FY2018-19 to FY2025-26)
· fetched 2026-08-24 01:36
| Line item | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹44.69 Bn | ₹46.32 Bn | ₹40.30 Bn | ₹57.18 Bn | ₹62.98 Bn | ₹68.93 Bn | ₹77.83 Bn | ₹91.28 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | ₹44.69 Bn | ₹46.32 Bn | ₹40.30 Bn | ₹57.18 Bn | ₹62.98 Bn | ₹68.93 Bn | ₹77.83 Bn | ₹91.28 Bn | SegmentRevenueFromOperations |
| Other Income | ₹0.92 Bn | ₹0.53 Bn | ₹0.47 Bn | ₹0.27 Bn | ₹0.62 Bn | ₹0.38 Bn | ₹0.67 Bn | ₹0.51 Bn | OtherIncome |
| Total Income | ₹45.62 Bn | ₹46.85 Bn | ₹40.77 Bn | ₹57.45 Bn | ₹63.59 Bn | ₹69.31 Bn | ₹78.50 Bn | ₹91.78 Bn | Income |
| Cost of Materials Consumed | ₹9.28 Bn | ₹9.64 Bn | ₹9.76 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹14.03 Bn | ₹14.55 Bn | ₹16.03 Bn | ₹18.38 Bn | ₹21.09 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹-0.46 Bn | ₹0.00 Bn | ₹0.15 Bn | ₹-0.08 Bn | ₹-0.20 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹9.14 Bn | ₹9.16 Bn | ₹8.49 Bn | ₹9.73 Bn | ₹10.47 Bn | ₹11.20 Bn | ₹11.67 Bn | ₹12.97 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹3.37 Bn | ₹2.05 Bn | ₹1.66 Bn | ₹1.47 Bn | ₹1.29 Bn | ₹1.31 Bn | ₹1.84 Bn | ₹3.14 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹2.33 Bn | ₹2.92 Bn | ₹2.91 Bn | ₹3.01 Bn | ₹3.16 Bn | ₹3.42 Bn | ₹3.86 Bn | ₹4.49 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹24.02 Bn | ₹21.43 Bn | ₹18.01 Bn | ₹23.18 Bn | ₹26.95 Bn | ₹28.87 Bn | ₹31.97 Bn | ₹36.58 Bn | OtherExpenses |
| Total Expenses | ₹48.14 Bn | ₹45.20 Bn | ₹40.82 Bn | ₹50.96 Bn | ₹56.41 Bn | ₹60.99 Bn | ₹67.65 Bn | ₹78.07 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹-2.52 Bn | ₹1.65 Bn | ₹-0.05 Bn | ₹6.49 Bn | ₹7.18 Bn | ₹8.32 Bn | ₹10.85 Bn | ₹13.72 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹-2.22 Bn | ₹0.62 Bn | ₹0.01 Bn | ₹3.15 Bn | ₹0.74 Bn | ₹0.16 Bn | ₹-0.89 Bn | ₹-0.22 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹-4.75 Bn | ₹2.27 Bn | ₹-0.04 Bn | ₹9.64 Bn | ₹7.92 Bn | ₹8.48 Bn | ₹9.96 Bn | ₹13.49 Bn | ProfitBeforeTax |
| Tax Expense | ₹1.14 Bn | ₹1.48 Bn | ₹0.99 Bn | ₹1.98 Bn | ₹1.81 Bn | ₹2.13 Bn | ₹1.98 Bn | ₹3.02 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹-2.24 Bn | ₹0.91 Bn | ₹-0.56 Bn | ₹7.90 Bn | ₹6.33 Bn | ₹6.45 Bn | ₹8.09 Bn | ₹10.64 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | N/A | ₹1.36 Bn | ₹-1.10 Bn | ₹5.55 Bn | ₹5.89 Bn | ₹5.99 Bn | ₹7.74 Bn | ₹10.42 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹-3.70 | ₹0.77 | ₹-1.45 | ₹7.35 | ₹7.80 | ₹7.93 | ₹10.26 | ₹13.80 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹-3.70 | ₹0.77 | ₹-1.45 | ₹7.35 | ₹7.80 | ₹7.93 | ₹10.26 | ₹13.80 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from FORTIS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).